Bain Irwin Allen 13D and 13G filings for Navidea Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-03 4:01 pm Unchanged |
2023-06-21 | 13G | Navidea Biopharmaceuticals, Inc. NAVB |
Bain Irwin Allen | 4,000,000 4.730% |
0 (Unchanged) |
Filing |
| 2023-06-30 4:01 pm Purchase |
2023-06-19 | 13G | Navidea Biopharmaceuticals, Inc. NAVB |
Bain Irwin Allen | 4,000,000 4.730% |
2,053,383 (+105.48%) |
Filing |
| 2022-10-06 2:51 pm Purchase |
2022-08-24 | 13G | Navidea Biopharmaceuticals, Inc. NAVB |
Bain Irwin Allen | 1,946,617 6.230% |
1,946,617 (New Position) |
Filing |